Research Topics
| David ArcherSummaryAffiliation: Eastern Virginia Medical School Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapyJulia V Johnson
Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, VT 05405, USA
Menopause 9:16-22. 2002..5 mg norethindrone acetate (Activella; E(2)/NETA group), a newly available CCHRT preparation, over a 6-month period...
Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cellsSebastian Mirkin
Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Menopause 11:82-8. 2004..We hypothesize, based on these data, that the clinical finding of no endometrial growth in women using tibolone may be partly related to alterations in these angiogenic factors...
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopauseDavid F Archer
Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Menopause 20:47-56. 2013..The current study was designed to estimate these events in desvenlafaxine versus placebo in a larger population followed for 1 year...
Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exerciseDavid F Archer
Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507 1912, USA
Contraception 87:212-9. 2013....
Postmenopausal skin and estrogenDavid F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Gynecol Endocrinol 28:2-6. 2012..This review explores the potential for targeted estrogen replacement as a therapeutic option for long-term skin management in postmenopausal women...
Vascular dysfunction as a cause of endometrial bleedingDavid F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Gynecol Endocrinol 28:688-93. 2012..Heavy menstrual bleeding (HMB) and the spotting and bleeding (S/B) associated with the use of hormonal contraceptives are distinct entities affecting endometrial vasculature and hemostasis...
Transdermal estradiol gel for the treatment of symptomatic postmenopausal womenDavid F Archer
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507 1912, USA
Menopause 19:622-9. 2012..The aim of this study was to determine the efficacy, safety, and lowest practical dose of a transdermal estradiol gel in the treatment of symptomatic postmenopausal women...
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trialDavid F Archer
Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507 1912, USA
Contraception 85:595-601. 2012....
Lower doses of oral estrogen and progestogens as treatment for postmenopausal womenDavid F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
Semin Reprod Med 23:188-95. 2005..The impact of lower doses of hormones on heart disease, and venous thromboembolism and stroke remain to be determined in future studies...
Neoplasia of the female reproductive tract: effects of hormone therapyDavid F Archer
Department of Obstetrics and Gynecology, Director, CONRAD Clinical Research Center, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
Endocrine 24:259-63. 2004..The data suggest a possible increase in ovarian epithelial tumors with >10 years use of estrogen only. There is no evidence of a change in the incidence of uterine cervical neoplasia with either estrogen or progestin...
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal womenDavid F Archer
CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Menopause 16:1109-15. 2009..The aim of this study was to evaluate the endometrial, ovarian, and breast safety of bazedoxifene used as a treatment for postmenopausal osteoporosis...
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safetyDavid F Archer
Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA, USA
Am J Obstet Gynecol 200:238.e1-238.e10. 2009..The objective of the study was to assess the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for the treatment of vasomotor symptoms...
Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine deviceD F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, USA
Contraception 59:175-9. 1999..IL-6 and TNF-alpha levels were increased in the intrauterine cavity of postmenopausal women with an IDS-P. These data suggest that secreted cytokines could be a potential mechanism of IUD contraceptive efficacy...
Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant usersDavid F Archer
CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 78:106-12. 2008..Women experiencing excessive S/B were enrolled in a multicenter prospective randomized study using EE, IBU or PL...
Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trialDavid F Archer
CONRAD Clinical Research Center, 601 Colley Avenue, Norfolk, VA 23507, USA
Menopause 12:716-27. 2005....
Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal womenDavid F Archer
Department of Obstetrics and Gynecology, Contraceptive Research and Development Program Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Fertil Steril 88:866-78. 2007..To address the endometrial safety of tibolone...
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current dataDavid F Archer
Department of Obstetrics and Gynecology and CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia, USA
J Reprod Med 52:159-64. 2007..In addition to providing effective and safe relief of menopausal symptoms, the combination has a beneficial effect on blood pressure and weight gain...
Endometrial bleeding during hormone therapy: the effect of progestogensDavid F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA, USA
Maturitas 57:71-6. 2007..No good therapeutic option to control the bleeding or spotting exists at this time. Evaluation and monitoring of the patient regarding endometrial safety is of paramount importance...
Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptivesDavid F Archer
Contraceptive Research and Development Program, Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 74:359-66. 2006..For women who do not wish to become pregnant, a continuous OC regimen should be an available option...
Endometrial effects of tiboloneDavid F Archer
CONRAD Clinical Research Center, 601 Colley Avenue, Norfolk, Virginia 23507, USA
J Clin Endocrinol Metab 92:911-8. 2007..25 or 2.5 mg/d). Tibolone was compared with continuous combined conjugated equine estrogen (CEE) plus medroxyprogesterone acetate (MPA) (0.625 + 2.5 mg/d)...
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study resultsDavid F Archer
CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 74:439-45. 2006..This study was conducted to evaluate the safety and efficacy of a continuous daily regimen of levonorgestrel (LNG) 90 microg/ethinyl estradiol (EE) 20 microg (continuous LNG/EE)...
Efficacy and tolerability of local estrogen therapy for urogenital atrophyDavid F Archer
CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA, USA
Menopause 17:194-203. 2010....
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenDavid F Archer
CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Fertil Steril 92:1039-44. 2009..To evaluate the effect of bazedoxifene/conjugated estrogens (BZA/CE), a tissue selective estrogen complex, on uterine bleeding in postmenopausal women...
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimenDavid F Archer
CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 80:245-53. 2009..A continuous regimen of oral levonorgestrel (LNG) 90 mcg/ethinyl estradiol (EE) 20 mcg was evaluated for inhibition of ovulation, time to return to ovulation after stopping treatment and safety...
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study GroupD F Archer
Clinical Research Center, Eastern Virginia Medical School, Norfolk 23507 1627, USA
Obstet Gynecol 94:498-503. 1999..To determine whether a continuous estradiol-norethindrone acetate transdermal delivery system reduces incidence of endometrial hyperplasia in postmenopausal women more than transdermal estradiol (E2) alone...
Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free intervalD F Archer
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507 1627, USA
Contraception 60:151-4. 1999..The endometrial histologic findings observed in this study were similar to those observed during the use of 21-day combination oral contraceptive regimens...
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleedingD F Archer
Jones Institute for Reproductive Medicine, Eastern Virginia Medical Center, Norfolk, Virginia 23507 1912, USA
Obstet Gynecol 96:899-905. 2000..To analyze the effects of two continuous combined hormone replacement regimens on bleeding profiles in postmenopausal women, based on progestin dose and time since the patient's last spontaneous menstrual period...
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleedingD F Archer
Jones Institute for Reproductive Medicine, Norfolk, Virginia 23507, USA
Fertil Steril 75:1080-7. 2001..To evaluate vaginal bleeding profiles with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) as continuous combined therapy...
The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal womenD F Archer
Department of Obstetrics and Gynecology, and Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia, USA
Menopause 8:245-51. 2001..The addition of a progestin to ERT reduces the incidence of endometrial cancer. The duration of progestin administration is more important than the dose...
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseDavid F Archer
Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Am J Obstet Gynecol 200:172.e1-10. 2009..The objective of the study was to assess the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for menopausal vasomotor symptoms...
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptomsDavid F Archer
Clinical Research Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia 23507 1912, USA
Drugs Aging 27:533-44. 2010....
Low-dose hormone therapy for postmenopausal womenDavid F Archer
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, USA
Clin Obstet Gynecol 46:317-24. 2003
Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal womenDavid F Archer
The Jones Institute for Reproductive Medicine, 601 Colley Ave, Second Floor, Norfolk, VA 23507 1627, USA
Menopause 10:516-21. 2003..To determine the efficacy and tolerability of two strengths of percutaneous 17beta-estradiol in a hydroalcoholic gel and placebo in controlling vasomotor symptoms of menopause...
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cellsDavid F Archer
The Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Fertil Steril 81:165-70. 2004..To determine the effect of 17beta-E(2), levonorgestrel, medroxyprogesterone acetate, and norethindrone on the expression of vascular endothelial growth factor (VEGF) isoforms 121 and 165 in Ishikawa cells in vitro...
Endometrial bleeding in postmenopausal women: with and without hormone therapyDavid F Archer
The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Menopause 18:416-20. 2011..The major cause of hormone therapy-related bleeding is unknown. Alterations in angiogenic factors that could result in vascular dysfunction and vessel breakdown provide a working hypothesis as to the potential cause of vessel breakdown...
Tailoring combination oral contraceptives to the individual womanDavid F Archer
Obstetrics and Gynecology, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
J Womens Health (Larchmt) 20:879-91. 2011..New formulations, including extended-cycle or continuous-use COCs or those that use a natural estrogen, estradiol, may offer improvements over their predecessors...
Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the mediaDavid F Archer
Department of Obstetrics and Gynecology, CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Pharmacoepidemiol Drug Saf 16:28-31. 2007
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometriumSebastian Mirkin
CONRAD Clinical Research Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, USA
Maturitas 57:338-46. 2007..We hypothesized that differential effects on angiogenic factors or inflammatory cytokines by individual hormones may be related to the endometrial bleeding in postmenopausal women using hormone therapy...
Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristoneSebastian Mirkin
The Contraceptive Research and Development Program, Clinical Research Center, The Jones Institute for Reproductive Medicine. Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
Contraception 70:327-33. 2004..We hypothesized, based on these data, that the clinical finding of endometrial antiproliferative effect and low vaginal bleeding rate observed in women using mifepristone may be related to lack of stimulation of these angiogenic factors...
Hormone therapy and endometrial angiogenesisSebastian Mirkin
The Jones Institute for Reproductive Medicine, CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Climacteric 6:273-7. 2003..These alterations could induce a unique pro angiogenic activity in the endometrial capillary plexus, with consequent aberrant vasculogenesis, which may result in irregular endometrial bleeding...
Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cellsSebastian Mirkin
The Contraceptive Research and Development Program, The Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
Fertil Steril 84:485-91. 2005....
Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implantShumei Zhao
Department of Obstetrics and Gynecology, CONRAD Clinical Research Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 79:469-78. 2009..Endometrial spotting and/or bleeding (ESB) occurs in levonorgestrel subcutaneous implant (LNG SI) users. Matrix metalloproteinases (MMPs) may play a role in ESB...
Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cellsFrancisco J Navarro
The Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia, USA
Fertil Steril 79:1409-15. 2003..Our hypothesis is that raloxifene's lack of endometrial stimulation may be partly mediated by an antiangiogenic effect...
A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observersSusan A Ballagh
CONRAD Clinical Research Center, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
Contraception 70:241-9. 2004..Colposcopy is used to evaluate effects of new vaginal products on cervicovaginal epithelium as part of the US Food and Drug Administration-mandated product approval process, yet few aspects of its use have been investigated...
Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cellsChainarong Choksuchat
CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Contraception 79:139-45. 2009..We evaluated apoptosis in human endometrial endothelial cells (HEECs) incubated with progesterone, levonorgestrel (LNG) and medroxyprogesterone acetate (MPA)...
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulationsBryna Harwood
Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL, USA
Am J Obstet Gynecol 198:32.e1-7. 2008..This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population...
The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacyDavid F Archer
Contraceptive Research and Development Program, Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA, USA
Contraception 69:189-95. 2004..The weekly change schedule of the transdermal contraceptive delivery system is associated with a significantly greater proportion of cycles in which there is perfect dosing compared to an OC...
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy studyChristine K Mauck
CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington 22209, USA
Contraception 70:77-83. 2004..To evaluate symptoms and signs of genital irritation, vaginal leakage and acceptability of polystyrene sulfonate (PSS), which is being studied as a vaginal contraceptive and microbicide...
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleedingRongxiu Li
Department of Obstetrics and Gynecology, University of Florida, Gainesville 32610-0294, USA
Hum Reprod 21:2555-63. 2006....
Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American womenDavid F Archer
Eastern Virginia Medical School, Norfolk, Virginia, USA
Fertil Steril 77:S27-31. 2002..The contraceptive patch is uniformly easy to use across all ages...
A phase I comparative postcoital testing study of three concentrations of C31GChristine K Mauck
CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington, VA 22209, USA
Contraception 70:227-31. 2004..5%, 1.0% and 1.7%, administered as a 3.5-mL dose of a vaginal gel to prevent sperm from entering mid-cycle cervical mucus. Irritation of the genitalia and acceptability were also assessed...
FemCap with removal strap: ease of removal, safety and acceptabilityChristine K Mauck
CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
Contraception 73:59-64. 2006..This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability...
Role of the nonhuman primate for research related to women's healthDavid F Archer
CONRAD Clinical Research Center, Norfolk, VA, USA
ILAR J 45:212-9. 2004..These findings allow us to utilize the nonhuman primate as the most relevant model in the animal world for the study of human disease processes...
Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokineRongxiu Li
Department of Ob Gyn, University of Florida, Gainesville, FL 32610, USA
J Reprod Immunol 73:118-29. 2007....
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cellsSebastian Mirkin
Fertil Steril 82:220-2. 2004..Progestins had less effects on TSP-1 mRNA compared to P, in Ishikawa cells, and this difference in TSP-1 expression by individual progestins may be associated with the irregular bleeding seen in women using progestin-only contraception...
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing errorRoger A Pierson
Obstetrics, Gynecology, and Reproductive Sciences, University of Saskatchewan, Saskatoon, Canada
Fertil Steril 80:34-42. 2003..To compare the effects of the contraceptive patch to oral contraceptives (OCs) on follicular size and incidence of ovulation in normal cycles and after dosing errors...
Continuous combined hormone replacement therapy and endometrial hyperplasiaDavid F Archer
BMJ 325:231-2. 2002
Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrelSidney Funk
Radiant Research, Atlanta, GA 30342, USA
Contraception 71:319-26. 2005..The return to normal menstrual cycles and fertility was rapid after removal. CONCLUSIONS: Implanon is a safe, highly effective and rapidly reversible new method of contraception...
Drospirenone, a progestin with added value for hypertensive postmenopausal womenDavid F Archer
Menopause 14:352-4. 2007
Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal womenMark Naunton
Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands
Menopause 13:517-27. 2006..To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin...
Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe)Steven T Nakajima
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Women s Health, University of Louisville, Louisville, KY 40202, USA
Contraception 75:16-22. 2007..Extending the duration of active hormonal treatment may reduce the frequency of intracyclic bleeding/spotting while maintaining efficacy and tolerability...
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptomsJeffrey T Jensen
Oregon Health and Science University, Department of Ob Gyn, UHN 70, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA
Expert Opin Pharmacother 9:319-27. 2008....
Progestogens: effects on clinical and biochemical parameters in postmenopausal womenDavid F Archer
Menopause 12:484-7. 2005
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal womenSheila Ronkin
Wyeth Research, Collegeville, Pennsylvania 19426, USA
Obstet Gynecol 105:1397-404. 2005..To assess the endometrial effects of bazedoxifene acetate in healthy postmenopausal women...
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause SocietyWulf H Utian
Menopause 15:584-602. 2008..The benefit-risk ratio for menopausal HT is favorable close to menopause but decreases with aging and with time since menopause in previously untreated women...
Progesterone receptor modulator for emergency contraception: a randomized controlled trialMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213, USA
Obstet Gynecol 108:1089-97. 2006..Compare the efficacy and adverse effects of CDB-2914, a new progesterone receptor modulator, to levonorgestrel for emergency contraception...
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart
University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Obstet Gynecol 110:577-86. 2007..The objective of this study was to assess the gel's contraceptive effects, safety, and acceptability...
Research Grants
- DOXYCYCLINE FOR BLEEDING IN PROGESTIN ONLY CONTRACEPTORSDavid Archer; Fiscal Year: 2006..If successful, DOX treatment could become an important adjuvant for treatment of this and possibly other inflammatory disorders effecting reproductive tract tissues. ..
